N4-Benzoyl-2’-deoxy-5-iodocytidine
N4-Benzoyl-2’-deoxy-5-iodocytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
158042-39-8
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/n4-benzoyl-2-deoxy-5-iodocytidine.html
Solubility
10 mM in DMSO
Smiles
O[C@H]1C[C@H](N2C=C(I)C(NC(C3=CC=CC=C3)=O)=NC2=O)O[C@@H]1CO
Molecular Formula
C16H16IN3O5
Molecular Weight
457.22
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Histone H1 (AE-4), CF640R conjugate, 0.1mg/mL
CD59 (heavy chain of Protectin) (BRA-10G), CF740 conjugate, 0.1mg/mL
Human IgG Immunoglobulin (IG266), CF640R conjugate, 0.1mg/mL
Fibronectin (TV-1), CF488A conjugate, 0.1mg/mL
